Telangiectasia hemorrágica hereditaria Síndrome de Osler Weber Rendú y manejo con bevacizumab / Hereditary hemorrhagic telangiectasia Osler Weber Rendu syndrome and management with bevacizumab
Acta méd. colomb
;
40(1): 66-68, ene.-mar. 2015. ilus, tab
Article
in Spanish
| LILACS, COLNAL
| ID: lil-755572
RESUMEN
Presentamos un caso clínico de una paciente con diagnóstico de telangiectasia hemorrágica hereditaria con múltiples manifestaciones sistémicas debidas a sangrados profusos, anemia severa y malformaciones arteriovenosas pulmonares, hepáticas y falla cardiaca de alto débito, con adecuada respuesta al uso de bevacizumab. (Acta Med Colomb 2015; 40 66-68).
ABSTRACT
The case of a patient diagnosed with hereditary hemorrhagic telangiectasia with multiple systemic manifestations due to profuse bleeding, severe anemia and pulmonary arteriovenous malformations, liver and heart failure high debit adequate response to the use of bevacizumab, is presented. (Acta Med Colomb 2015; 40 66-68).
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Telangiectasia, Hereditary Hemorrhagic
Limits:
Female
/
Humans
Language:
Spanish
Journal:
Acta méd. colomb
Journal subject:
Medicine
Year:
2015
Type:
Article
Affiliation country:
Colombia
Institution/Affiliation country:
Hospital Pablo Tobón Uribe/CO
Similar
MEDLINE
...
LILACS
LIS